1-4 of 4
Keri Toner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Leukapheresis in Patients with B-ALL Yields an Activated, Early Memory T-Cell Phenotype Associated with Response to CAR T-Cell Therapy

Alexandra Dreyzin, Yihua Cai, Kyu Lee Han, Michaela Prochazkova, Jennifer Webb, Keri Toner, Kathryn Bushnell, Bonnie Yates, Ping Jin, David F. Stroncek, Nirali N. Shah
Journal: Blood
Blood (2024) 144 (Supplement 1): 4853.
https://doi.org/10.1182/blood-2024-199264
Published: 2024
Journal Articles

Identifying Tumor-Specific Immune Response and Biomarkers of High-Risk Hodgkin Lymphoma Patients Treated with and without Brentuximab on Children's Oncology Group Trial AHOD1331

Keri Toner, Hema Dave, Gloria Pezzella, Qinglin Pei, Terzah M. Horton, Kara M. Kelly, Lisa Giulino Roth, Sharon M. Castellino, Catherine M. Bollard
Journal: Blood
Blood (2023) 142 (Supplement 1): 4383.
https://doi.org/10.1182/blood-2023-180791
Published: 2023
Journal Articles

EBV + lymphoproliferative diseases: opportunities for leveraging EBV as a therapeutic target

Keri Toner, Catherine M. Bollard
Journal: Blood
Blood (2022) 139 (7): 983–994.
https://doi.org/10.1182/blood.2020005466
Published: 2022
Journal Articles

Tumor Associated Antigen Specific T Cells Given in Combination with Nivolumab for the Treatment of Hodgkin Lymphoma

Hema Dave, MDMPH, Mimi Mai, Madeline Terpilowski, BS, Keri Toner, MD, Maja Stanojevic, MD, Morgan Galligan, BS, Abeer Shibli, BS, Melanie Grant, PhD, Christopher Lazarski, PhD, Philip Y Maglo, BS, MPH, Nan Zhang, PhD, Jay Tanna, MS, Richard F. Ambinder, MD, Martha Glenn, MD, Patrick Hanley, PhD, Catherine M. Bollard, MD MBChB
Journal: Blood
Blood (2020) 136 (Supplement 1): 18.
https://doi.org/10.1182/blood-2020-142422
Published: 2020